ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)

NCT07741461 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepaititis B

Interventions

DRUG: ACT201 Injection
DRUG: ACT201 Injection Placebo

Sponsor

Xiamen Amoytop Biotech Co., Ltd.

Collaborators

[object Object]